Professional Documents
Culture Documents
BACTERIAL STRUCTURE
OUTLINE
I Introduction to Antimicrobials
A Subtopic A
II Beta-Lactam Compounds
A Cephalosporins and Cephamycins
B Other Beta-lactam Drugs
III Glycopeptide Antibiotics
IV Other Cell Wall- or Membrane-Active Agents
SELECTIVE TOXICITY
➔ antibacterials will be toxic to the pathogen but
not in the human cells
➔ a bacteria can be a gram negative or a gram ➔ Beta lactams are the most popular which are
positive bacteria depending on its cell wall penicillins and cephalosporins
➔ in the past, anything above the umbilicus ➔ does not contain beta lactam ring are:
(pusod) would mostly be a gram-positive ◆ carbapenems, aztreonam, and
bacteria i.e. sore throat, lung infection while vancomycin
anything below the umbilicus i.e. UTI, wound ➔ when a bacteria did not produce a cell wall, it
on the feet, diarrhea would be a will be susceptible to the immune defences
gram-negative bacteria making it easier to be killed
◆ but because of the mutation of ➔ usually beta lactams are divided into two
bacterial pathogenicity, it has already which are:
changed ◆ narrow spectrum
➔ a gram-positive cell wall would have thick ● can also be classified whether
layer of peptidoglycan layer it is
➔ a gram-negative cell wall would have a thin ○ penicillinase
peptidoglycan layer, however the cell wall susceptible - an
would have another layer known as the outer enzyme the can break
membrane which is also a lipid bilayer similar the beta lactam
to the plasma membrane ○ penicillinase resistant
➔ peptidoglycan are likely to be hydrophilic ● advantage is that it can target
compared to the outer membrane because of specific organisms
its lipid major, it is hydrophobic ● in the case of the Philippines
◆ this peptidoglycan cannot just be where culture and sensitivity
disrupted, the reason why this is of antibiotics are not routinely
harder to kill gram-negative bacteria done, it is not applicable since
it would be costly
◆ wider spectrum
● disadvantage of this is that it
will also affect other
commensal/non-pathogenic
bacteria
HISTORY OF PENICILLIN
➔ Penicillin is a serendipitous discovery when
Alexander Flemming was growing an organism
➔ peptidoglycan is a repeating units of NAG and which happens to be contaminated by a
NAM bacteria and saw that where the Penicillin
◆ carbohydrates grows, it inhibits the contaminating mold
➔ these are interconnected by the Tetrapeptide
Cross-Linking which makes it tough and harder SIR ALEXANDER FLEMMING
to be penetrated
◆ the four amino acids in the
Tetrapeptide Cross-Linking are:
● L - alanine
● D - glutamine
● L - lysine
● D - alanine
PENICILLINS
➔ Derivatives of 6-aminopenicillamic acid and
contain a peculiar beta lactam ring structure
◆ peculiar because the ring formation 2. β-lactam ring (B) that carries a
usually would require at least five secondary amino group (RNH–)
members, however these
four-member ring, the steering effect R GROUPS
would likely to be seen as can easily
disrupted
● however this is a stable beta
lactam ring from which
penicillins and cephalosporins
are built on
6-AMINOPENICILLANIC ACID
PHARMACOKINETICS
➔ Vary in their oral F (absorption)
➔ Penicillins – polar and not metabolized
➔ the beta lactam ring is the one that is extensively
hydrolyzed by penicillinase, an enzyme ◆ Excreted unchanged in urine
produced by resistant bacteria ● most of the earlier generation
➔ the nature of the R group would usually penicillins would have more
determine the specific beta lactam stability to gram-positive which are
acid which explains why some drugs cannot below the umbilicus
be taken orally because of the acid in the ● most of the UTI would be
stomach gram-negative
◆ Inhibited by Probenecid
BETA-LACTAM COMPOUNDS ➔ Cross the BBB when meninges are inflamed
◆ the reason why some penicillins are
used in treating meningitis
➔ Must be given on an empty stomach (to
improve absorption); except Amoxicillin
MECHANISM OF ACTION
◆ Modification of PBP
◆ Changes in membrane permeability
● causes resistance
CLINICAL USES
➔ Narrow spectrum penicillinase susceptible
agents
➔ Bactericidal drugs
➔ Inhibit cell wall synthesis
1. Binds to PBP (Penicillin Binding
Protein) regions of the bacteria
● in the cytoplasmic membrane
● it needs to enter in the porins
to bind in the PBP and by
doing so it inhibits
transpeptidation 1. Penicillin G
2. Inhibits transpeptidation ● limited spectrum; susceptible
● transpeptidation is like to β-lactamases
weaving the layers of ● For streptococci (causes sore
peptidoglycan throat), meningococci (causes
● when peptidoglycans are not meningitis), gram-positive
able to bind on one another, it bacilli, spirochetes i.e.
can easily sluff off sexually-transmitted syphilis
3. Activation of autolytic enzymes ● Benzathine Penicillin G – first
● causing the peptidoglycan line drug for syphilis; IM
layer to be disintegrated ○ single intramuscular
injection
➔ on gram-positive bacteria which has a thick 2. Penicillin V – P.O.
peptidoglycan, the target of the penicillin, it
will be more effective but for the ➔ Very Narrow spectrum penicillinase resistant
gram-negative bacteria that has an outer agents – against Staphylococcus aureus
membrane, it will manifest some of the (antistaphylococcal penicillins) for skin
resistance is the inhibition of the penicillins to infections
enter the outer membrane
◆ Methicillin
● a prototype drug
◆ Oxacillin
● available in the market
◆ Cloxacillin (Dicloxacillin)
➔ Inhibit transpeptidation reaction of bacterial ● available in the market
cell wall synthesis ◆ methicillin group, because of its
shorter half-life, it is taken 4x a day
➔ Resistance: (every 6 hours)
R1 AND R2 GROUPS
➔ Giuseppe Brotzu
◆ Isolated Cephalosporin C compound
in from the fungus Acremonium,
previously known as
"Cephalosporium” in 1945.
◆ Found in the sea near a sewage outfall
in Su Siccu, by Cagliari harbour in
Sardinia, Italy
PHARMACOKINETICS
➔ Most are parenteral
CEPHALOSPORINS AND CEPHAMYCINS ◆ there are oral preparations i.e.
➔ “mycins” pertains that they are of fungal cephalexin, especially the older
origin generations
➔ More stable to many bacterial β–lactamases, ➔ Major elimination is by renal excretion
has broader spectrum of activity (water-soluble); some with side chains –
➔ With 2 sites of attachment for various R1 and hepatic metabolism
R2 groups ➔ Cefoperazone and ceftriaxone – excreted in
◆ whether it is hydrophobic or the bile
hydrophilic; whether it can traverse ➔ 1st and 2nd generation: do not cross BBB even
the BBB or not in inflamed meninges
7-AMINOCEPHALOSPORANIC ACID MECHANISM OF ACTION AND RESISTANCE
➔ Bind to PBP – inhibit cell wall synthesis, similar
to penicillins
➔ Cephalosporins are bactericidal
➔ Structural differences render them less
susceptible to penicillinases produced by
staphylococci
◆ Some organisms are resistant through
production of other beta-lactamases
vs cephalosporins
➔ MRSA (Methicillin-Resistant Staphylococcus
Aureus) – resistant to cephalosporins
CLINICAL USES
➔ 1st Generation Drugs:
◆ has better coverage to gram-positive
bacteria
◆ Cefazolin and cephalexin – against G+
➔ R group at 7-position: alters antibacterial cocci, E coli, K (Klebsiella) pneumoniae
activity
➔ R group at 3-position: modifies
pharmacokinetic profile
CLASSIFICATION OF CEPHALOSPORINS
1ST 2ND 3RD 4TH
GENERATION GENERATION GENERATION GENERATION
➔ 2nd Generation Drugs:
Cefazolin, Cefaclor, Cefotaxime Cefepime
◆ as the generation gets further in the cefadroxil, cefamandole (prototype
generation of cyclosporine, it loses its cephalexin , cefonicid, drug),
activity coverage on gram-positive but (prototype cefuroxime, ceftazidime,
develops extension to gram-negative drug), cefprozil, ceftizoxime*
cephalothin, loracarbef, , ceftriaxone,
◆ Less activity against G+, extended G-
cephapirin, and cefixime,
overage cephradine ceforanide cefpodoxime
◆ Anaerobic coverage: Cefotetan, proxetil,
Cefoxitin cefdinir,
◆ H influenzae (can cause meningitis), M cefditoren
pivoxil,
catarrhalis: Cefamandole, cefuroxime, ceftibuten,
cefaclor moxalactam*
● most of the ,
meningitis-causing bacteria cefoperazone
Coverage: * Coverage:
starts if with a respiratory
same as 1st Pseudomona
tract infection which can be Coverage: gen but with Expanded s,
covered by these drugs Gr(+) cocci, extended Gram-negati Enterobacter
E.coli, K Gr(-) ve coverage: iaceae ,
➔ 3rd Generation Drugs – Ceftazidime, pneumoniae, activityKlebsi Citrobacter, methicillin-su
and Proteus ella, H. serratia, sceptible S.
cefoperazone, cefotaxime mirabilis influenzae, providencia, aureus, S.
◆ Increased activity for G-; penetrates Bacteroides Pseudomona pneumoniae.
BBB (except Cefoperazone and fragilis, s ,
Cefixime) Serratia (Ceftazidime) Haemophilus
and Neisseria
◆ Ceftriaxone = gonococcal urethritis
sp.
● prototype for third generation
cephalosporins; IV Penetrates
well into
Some able to cerebrospina
cross the l fluid
blood-brain-
Not useful barrier Useful in
against treatment of
Enterobacter Not useful Enterobacter
against infections
Enterobacter
➔ 4th Generation Drugs:
*No longer commercially available
◆ Cefepime – more resistant to beta
lactamases; combines gram positive
SOME CEPHALOSPORIN GENERATILITES
activity of 1st gen. with wider gram
➔ First generation cephalosporins are
neg. spectrum of 3rd gen.
predominantly active against Gr(+)’s, with
◆ Ceftaroline – active against MRSA
succeeding generations progressively more
TOXICITY
active against Gr(-) strains (often with reduced
Gr(+) activity except 4th generation, which are
➔ Allergy – from rashes to anaphylactic shock
extended spectrum agents)
◆ Complete cross reactivity should be
➔ Cephalosporins are “LAME” because they are
assumed
inactive against atypical causes of pneumonia:
◆ (Partial) Cross reactivity between
◆ Listeria
penicillin and cephalosporin : 5-10%
◆ Atypicals
● before giving IV antibiotics, a
◆ Methicillin-resistant staphylococcus
skin test is first performed
aureus (MRSA) - except Ceftaroline
CARBAPENEMS
BACITRACIN
➔ Isolated from the bacterium Amycolatopsis
orientalis
➔ Coverage: bactericidal against Gram-positive
cocci and anaerobes (i.e. Enterococcus
faecium); Active against MRSA
➔ the drug of choice for MRSA ➔ Obtained from the Tracy strain of Bacillus
◆ there is already the presence of subtilis in 1943
vancomycin-resistant MRSA ➔ Coverage: gram-positive microorganisms
➔ Similar drug: Teicoplanin ➔ usually for topical use; highly nephrotoxic
when given systemically
➔ Mechanism of action: Inhibits cell wall
formation by interfering with the lipid carrier
that transfers peptidoglycan subunits to the
growing cell wall
➔ Adverse reaction: highly nephrotoxic when
administered systemically
➔ MOA – binds to D-Ala-D-Ala terminal of ➔ Clinical use: topical antibiotic
peptidoglycan; inhibits transglycosylation
◆ the terapeptide that cross-links the CYCLOSERINE
peptidoglycan layer (D-Ala terminal)
does inhibits the transglycosylation
➔ Adverse reaction – red man syndrome (also
known as the red neck syndrome
◆ develop rash on the face and neck
◆ very prominent to caucasians; not
➔ Produced by Streptomyces orchidaceous
readily seen in the Philippines
➔ Mechanism of action: inhibits incorporation of
➔ this drugs is reserved for septic toxic patients
d-alanine into peptidoglycan pentapeptide by
confined in the ICU setting
inhibiting alanine racemase, which converts
FOSFOMYCIN l-alanine to d-alanine, and d-alanyl-d-alanine
ligase
➔ Pharmacokinetics: widely distributed in
tissues, excreted in urine
◆ applicable for soft tissue infection,
respiratory, and UTI
➔ Clinical use: treatment of tuberculosis caused
by strains of Mycobacterium tuberculosis
➔ another cell wall active antibiotic resistant to first-line agents
➔ Antimetabolite inhibitor of enolpyruvate ◆ second-line drug for TB especially for
transferase -nan important enzyme in the patients that are MDR
addition of phosphoenolpyruvate ➔ Adverse reactions: headaches, tremors, acute
◆ Inhibits addition of psychosis, and convulsions
phosphoenolpyruvate to ◆ since it can penetrate the CNS
UDP-N-acetylglucosamine
➔ Monurol (brand name) is a single dose drug DAPTOMYCIN
➔ Coverage: gram-positive and gram negative ➔ Fermentation product of Streptomyces
roseosporus
REFERENCES
REFERENCES